Skip to main content
. 2024 Jan 23:22925503231225480. Online ahead of print. doi: 10.1177/22925503231225480

Table 1.

Characteristics of Included Primary Studies.

Author Year Design Journal Domain Facial aesthetic procedure Procedure details Risk of bias FACE-Q Aesthetic Scales Time horizon
Face overall Psychological Social
An et al 13 2022 Observational Aesthetic Plast Surg. Surgical Rhinoplasty Rhinoplasty with full-face fat transfer High NR
Berenguer et al 14 2022 Observational J Plast Reconstr Aesthet Surg. Surgical Forehead lift Primary isolated aesthetic forehead reduction Low NR
Berger et al 15 2019 Observational Aesthetic Plast Surg. Surgical Facelift SMAS Rhytidectomy Some concerns 12 months
Burks et al 16 2022 Observational Laryngoscope Surgical Rhinoplasty Group A: Septorhinoplasty with spreader graft placement and component dorsal hump reduction
Group B: Septorhinoplasty with spreader graft placement
Some concerns NR
Chen et al 17 2021 Observational Aesthet Surg J. Surgical Blepharoplasty Transconjunctival lower blepharoplasty High 11 months
Denadai et al 18 2019 Observational J Clin Med. Surgical Orthognathic surgery Orthognathic surgery Low 12 months
Denadai et al 19 2020 Observational Plast Reconstr Surg. Surgical Orthognathic surgery Orthognathic surgery Some concerns NR
Domela Nieuwenhuis et al 20 2022 Observational Aesthet Surg J. Surgical Upper blepharoplasty Upper blepharoplasty Some concerns 12 months
Fuller et al 21 2019 Observational JAMA Facial Plast Surg. Surgical Rhinoplasty Septorhinoplasty with spreader graft placement High 6 months
Gualdi et al 22 2017 Observational Aesthetic Plast Surg. Surgical Facial rejuvenation Minimal undermining suspension technique High 12 months
Hismi et al 23 2021 Observational Facial Plast Surg Aesthet Med Surgical Rhinoplasty Group A: Septorhinoplasty with spreader graft and alar rim graft
Group B: Septorhinoplasty with spreader graft and lateral crural strut graft
Group C: Septorhinoplasty with spreader graft
High NR
Hollander et al 24 2022 RCT Int J Oral Maxillofac Surg Surgical Upper blepharoplasty Group A: Upper blepharoplasty with orbicularis oculi muscle excision
Group B: Upper blepharoplasty
Low 12 months
Liu et al 25 2019 Observational Aesthetic Plast Surg. Surgical Hair transplant Follicle unit extraction Some concerns 6 months
Schwitzer et al 26 2015 Observational Aesthet Surg J. Surgical Rhinoplasty Group A: Women
Group B: Men
Some concerns 7 months
Schwitzer et al 27 2015 Observational Plast Reconstr Surg. Surgical Rhinoplasty Rhinoplasty Some concerns 5 months
Soni et al 28 2020 Observational J Laryngol Otol. Surgical Rhinoplasty Rhinoplasty High 6 months
Tan et al 29 2020 Observational J Craniomaxillofac Surg. Surgical Orthognathic surgery Group A: Orthognathic surgery for dento-skeletal class II patients
Group B: Orthognathic surgery for dento-skeletal class III patients
Some concerns 16 months
Tuin et al 30 2022 Observational Plast Reconstr Surg. Surgical Facial rejuvenation Facial fat grafting Low 12 months
Wang et al 31 2018 Observational Ann Plast Surg. Surgical Facelift Subcutaneous face and neck lift Some concerns 12 months
Wang et al 32 2021 Observational Aesthet Surg J. Surgical Facelift Periauricular purse-string reinforced with SMAS plication and malar fat pad elevation Some concerns 11 months
Weitzman et al 33 2021 Observational Laryngoscope Surgical Rhinoplasty Group A: Septorhinoplasty with extended spreader graft
Group B: Septorhinoplasty with standard spreader graft
High NR
Weitzman et al 34 2022 Observational Laryngoscope Surgical Rhinoplasty Group A: Septorhinoplasty with spreader graft with upper lateral cartilage release
Group B: Septorhinoplasty with spreader graft
High NR
Cohen et al 35 2022 Observational Aesthet Surg J. Non-surgical Facial rejuvenation OnabotulinumtoxinA for dynamic rhytids, hyaluronic acid filler for volume restoration and/or for lines and folds, bimatoprost ophthalmic solution 0.03% for eyelash hypotrichosis High 4 months
Hersant et al 36 2017 Observational Lasers Surg Med. Non-surgical Facial rejuvenation Er:YAG + SMA lazer High 6 months
Iorio et al 37 2012 Observational Aesthetic Plast Surg. Non-surgical Facial rejuvenation OnabotulinumtoxinA and hyaluronic acid filler High 1 week
Kerscher et al 38 2022 Observational Clin Cosmet Investig Dermatol. Non-surgical Facial rejuvenation Cell-free blood secretome High 48 weeks
McKeown et al 39 2021 Observational Plast Reconstr Surg Glob Open. Non-surgical Facial rejuvenation Hyaluronic acid filler and/or with onabotulinumtoxinA High 2 weeks
Ogilvie et al 40 2020 RCT Aesthet Surg J. Non-surgical Chin augmentation Hyaluronic acid filler High 18 months
Ozer et al 41 2019 Observational J Craniofac Surg. Non-surgical Facial rejuvenation Micro-autologous fat transplantation with platelet-rich plasma injection High 9 months
Ozer et al 42 2021 Observational Aesthetic Plast Surg. Non-surgical Facial rejuvenation Autologous biologic vitamin-C-added filler High 4 months
Qureshi et al 43 2017 Observational Aesthetic Plast Surg. Non-surgical Facial rejuvenation onabotulinumtoxinA/incobotulinumtoxinA and/or soft-tissue filler High 1 month
Santorelli et al 44 2021 Observational J Cosmet Dermatol. Non-surgical Facial rejuvenation Thread suspension technique High 6 months
Tebbens et al 45 2019 Observational J Sex Med. Non-surgical Facial feminization/
masculinization
Group A: Transwomen
Group B: Transmen
Low 12 months
Van Dongen et al 46 2021 RCT Aesthet Surg J. Non-surgical Facial rejuvenation Group A: Lipofilling + platelet-rich plasma + tissue stromal vascular fraction
Group B: Lipofilling + platelet-rich plasma
High 12 months
Weinkle et al 47 2018 Observational Aesthet Surg J. Non-surgical Facial rejuvenation OnabotulinumtoxinA for dynamic rhytids, hyaluronic acid filler for volume restoration and/or for lines and folds, bimatoprost ophthalmic solution 0.03% for eyelash hypotrichosis High 4 months

RCT, Randomized control trial; NR, Not reported.